Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-28

Clinical Trial Update: Early Immunosuppressants in Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on early immunosuppressants for Crohn's disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Early Immunosuppressants (immunosuppressant)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED